• Transparancy of qualtity of care goes beyond mortality rates

    Zorgvisie – December 3rd, 2012

    In December 2012 a number of hospitals made their mortality rate or so called HSMR (Hospital Standarised Mortality Ratio) public. This is an important step towards transparency of quality of care delivery.  However, we cannot rely on HSMR warns Piet-Hein Buiting the new CEO of Santeon (joint force of six top clinical Dutch hospitals). Comparing hospitals based on HSMR is unreliable and the number tells us nothing about the performance of individual departments. If we really want to give insight in quality of care, we need more specific data. In this respect Piet-Hein Buiting praises Meetbaar Beter, the joint effort of  the heart centres of Catharina  Hospital, St. Antonius Hospital Nieuwegein and The Decision Group.

    Outcome Measures

    With the Value Based Healthcare Center Europe, The Decision Group strives to develop patient relevant medical outcome measures that facilitate decision making and dialogue, making quality comprehensible. We provide clear insight in the whole cycle of care around a medical condition. Together with medical specialists, professionals and patients, the outcomes that are most relevant for the patient are successfully determined. Our methodology was successfully implemented in the project Meetbaar Beter.

    If you are interested to learn more about Value Based Healthcare and the use of Outcome Measures, please refer to our Clinical Management Workshop Series and our specialized Masterclasses Value Based Health Care.

    Visit our Value Based Health Care Center and learn, share and inspire!

    Continue reading
  • Meetbaar Beter Outcome Books available for download

    The first outcome measures and results for several medical conditions in cardiology are known! Download the Meetbaar Beter books by clicking the seperate books for the Heart Centers of Catharina and St Antonius hospitals.

    Meetbaar Beter – Value Based Health Care

    With Meetbaar Beter, The Decision Group, together with the cardiologists and cardio thoracic surgeons of Catherina and St Antonius Nieuwegein Hospitals developed patient relevant medical Outcome Measures for 5 medical conditions in cardiology and new medical conditions are being explored.

    Meetbaar Beter is based on the concepts of Value Based Health Care.  The outcome measures are developed from the perspective of the patient. What are the value adding activities for the patient and how can value be measured? Learn more and visit the dedicated website: www.vbhc.nl

    Learn More? Masterclass Outcome Measures – October 30

    Learn how Outcome Measures can be developed and implemented during the Masterclass Outcome Measures of  October 30, 2012 or March 6th, 2012.  Sign up or send an email to Niels van Gorp for more information. Best practices in the field of clinical management are discussed at the Clinical Management Workshop Series based on Harvard Business Cases. Discover how the Cleveland Clinic implemented outcome measures or how Intermountain optimized its processes. Visit the website for more information.

    Continue reading
  • Compliments for Meetbaar Beter & Value Based Health Care

    The first outcome measures and results for several medical conditions in cardiology are known! More than 250 visitors attended the impressive symposium in the Ruwenberg St. Michielsgestel on October 12, 2012. Prof. Dr. Fred van Eenennaam, partner of The Decision Group, led the afternoon, and told how Value Based Health Care works and how the outcome measures have been established.

    Patient Value

    The outcome measures are developed from the perspective of the patient. What are the value adding activities for the patient and how can value be measured? Maarten Koomans, partner of The Decision Group and chairman of Value Based Health Care Center Europe explains: “The results are for the total care of the patient. Not limited to the hospital and not only for the treatment by the medical specialist.” This is underlined by Dennis van Veghel, project leader Meetbaar Beter. “We give the patient insights into what he or she may expect of us”.

    Support

    The patient organization Heart & Vascular Group was enthusiastic about the approach. It is: “durven, doen en doorpakken“. The Consumentenbond added: “There is widespread support created and it is started by the medical specialist“. The cardiologists and cardio thoracic surgeons have worked with The Decision Group to develop  outcome measures. “It’s works like a mirror,” admits Jacques Koolen cardiologist Catharina Ziekenhuis. Through intensive collaboration we learned from each other, and the dialogue was based on quality.

    Enthusiasm

    Several websites (nu.nl, skipr, zorgvisie), radio (radio 1) and television (including nos-journal) paid attention to the symposium. Achmea Senior Medical Advisor Ben Crul complimented Meetbaar Beter with its speed and scientific argumentation. Joel Gijzen Director Zorg Inkoop CZ stressed that attention should be paid on improving the care process with outcome measures as a clear internal quality control. Comparing with other hospitals is secondary. VGZ Maarten van der Vorst shared the view of Achmea and CZ and was particularly pleased with the acceptance of the field.

    Meanwhile, four hospitals indicated to participate in Meetbaar Beter. Veronique Esman-Peeters Director Curatieve Zorg hopes that people will cooperate with Meetbaar Beter. She is very happy with the speed of the project.

    Learn More?

    Learn how Outcome Measures can be developed and implemented during the Masterclass Outcome Measures of  October 30, 2012. Sign up or send an email to Niels van Gorp for more information. Best practices in the field of clinical management are discussed at the Clinical Management Workshop Series based on Harvard Business Cases. Discover how the Cleveland Clinic implemented outcome measures or how Intermountain optimized its processes. Visit the website for more information.

    Continue reading
  • Patient Relevant Medical Outcome Measures for Cardiology

    On October 12 2012, for the first time in the Netherlands, patient relevant medical Outcome Measures will be presented. The Decision Group, together with the cardiologists and cardio thoracic surgeons of Catherina and St Antonius Nieuwegein Hospitals developed patient relevant medical Outcome Measures for 5 medical conditions in cardiology.

    Symposium MeetBaar Beter

    The results of  MeetBaar Beter  (measurably better) will be presented on a special symposium. The initiative has been embraced by all stakeholders in the field and it is supported by specialists. The Outcome Measures are developed to facilitate decision making and dialogue  at all levels  and have already led to improvements in the quality of care delivered at the two hospitals. The full program can be found on the dedicated website Meetbaar Beter.

    Develop Outcome Measures for your specialism

    The Decision Institute offers together with the Value-Based Health Care Center Europe, a range of workshops and masterclasses. Learn how you can implement Outcome Measures in our Masterclass Outcome Measures on 30 October 2012. Subscribe now via our website for our accredited programs or send an email to Niels van Gorp for more information.

    Continue reading
  • Prosensa – Dutch biotech success

    Prosensa is a succesful biotech company in the Dutch Life Sciences Cluster. In January 2012 it closed the Series C round and raised another $30 million, by a large international investor.  Prosensa has grown from a small startup to a renowned Dutch biotech company in the development of a treatment from “bench to bed” for orphan diseases.

    Partner The Decision Institute has written a Harvard Style Business Case about the company and its search for a treatment for Duchenne Muscular Dystrophy, a rare genetic disorder. The objective is to demonstrate the best practices of the Dutch biotech cluster. What can we learn from Prosensa and the biotech cluster? What are their strategies to bind large investors? Thanks to Leiden University, LSH, LUMC, NGI, PGGM, Prosensa, The Decision Institute and expecially all interviewees and editors who made it possible to develop the The Prosensa Case; Pioneering & Partnering. The case and the experiences of The Decision Group can help you to bind international partnerships for your strategic next steps.  

    Biotech and The Decision Group.

    Since 1998,  extensive expertise is built in biotech and life sciences. Out portfolio contains a wide range of projects for big pharma, medical device companies and biotech companies. Scenario analysis and strategic reviews as well as helping  to create patient centered relations with customers and realizing growthpotential in the cost-cutting market..
    Furthermore, The Decision Group monitors clusters success in Life Sciences & Health. The Dutch Life Sciences & Health Outlook measures performance and progress of the industry and benchmarks with succesful clusters worldwide. The aim of the Outlook 2013 is also to address the convergence to healthcare. Innovation from Bench to Bed.

    • Learn more on scenario planning and cluster monitoring by visiting the website advanced strategic tools.
    • Request your copy of the Dutch Life Sciences Outlook here.
    • Send an e-mail to Kim Bruheim to learn more on the possibilities with the new case.
    • See also:

    The Decision Group:
    Consulting on Competitiveness & Clusters
    Consulting on Life Sciences
    Dutch Life Science Outlook

    The Decision Institute: Clusters and Competitiveness:
    The Netherlands Institute of Competitiveness
    Microeconomics of Competitiveness

    Executive programs:
    Strategy & Governance Excellence Series

    Continue reading
  • Access to large network provided to USA health professionals

    An enthusiastic group of academic health administration professionals visited The Netherlands last week. Together with AUPHA, The Decision Group’s affiliate The Decision Institute organized a study tour of the Dutch Healthcare System. The purpose of tour was to provide new ways to think about specific health management and policy issues. How the Netherlands has excelled or experimented with innovative programs and what are the unique challenges to learn from.

    Large (academic) network

    A large network of main players in healthcare was provided; from policy makers, and (academic) hospitals till insurers and patient organisations.  The connections of The Decision Group were the focus of this week. The group visited amongst others the Ministry of Health, Menzis Healthcare and the Catharina Ziekenhuis. The participants were impressed by the Dutch System. The approval of the Obama Care Act gave a special touch to the tour.

    • Visit our Healthcare page, to learn more on our Healthcare projects and methods.
    • Read the blog of the CEO of AUPHA Lydia Middleton for more information on the activities of the special week.  
    • Contact ir. Niels van Gorp to connect to our large healthcare & academic network or for further questions.

    See also

    – The Decision Group Healthcare Consulting
    – The Decision Group Life Sciences Consulting

    Executive Education Programs Healthcare by affiliate The Decision Institute: 
    Clinical Management Workshop Series
    Masterclasses Value Based Health Care
    Masterclass Healthcare ‘New&Improved’

    Continue reading
  • The Decision Group Framework: a new way of looking at diagnostics

    At the successful event on The Value of Diagnostics of June 5th 2012, The Decision Group Framework was launched. This decision framework for diagnostics will help organizations to asses the value of diagnostics. The framework and methodology received very positive replies from the audience:

    • The event was very usefull and inspiring. It gave me a new vision on how to interpret costs and value. – Medical specialist
    • The Decision Framework is innovative and can result in product improvement. The Value of Diagnostics is the ‘new thinking’  – Director of Life Sciences company
    • The Decision Group succeeded to open a new discussion on diagnostics, via a differen point of view and a practical approach’  – Head Clinical Chemistry

    A large variety of stakeholder groups were present at the event. A sample of the companies and organisations represented:

    Borstkankervereniging Nederland IKNL
    Check-Points B.V.  Isala Klinieken
    Citeq Health Products Ned. Ver. voor Radiologie
    De Friesland Zorgverzekeraar Nucletron
    Diaconessenhuis Meppel NVOG
    Distrilab BV Philips Healthcare Benelux
    E-nose Radboud University Nijmege MC
    Erasmus MC Roche Diagnostics Nederland
    Flevoziekenhuis Saltro 
    Forbion Capital Partners Saxenburgh groep
    GE Healthcare St Lucas Andreas Ziekenhuis
    Glaxo Smith Kline Virtual Proteins BV
    Haga Teaching Hospital Vu University Medical Center
    Hycult Biotech  

     

    During the discussion it became clear that this new approach brings high added value for the different stakeholders.  Actions to learn more:

    See also

    – The Decision Group Healthcare Consulting
    – The Decision Group Life Sciences Consulting

    Executive Education Programs Healthcare by affiliate The Decision Institute: 
    Clinical Management Workshop Series
    Masterclasses Value Based Health Care
    Strategy & Goverancence Excellence Series
    Masterclass Healthcare ‘New&Improved’

    Continue reading
  • The Value of Diagnostics – Launch Event on June 5th, 2012

    Did you know that in The Netherlands:

    • Diagnostics influences as much as 60-70% of healthcare decision making
    • Expenditure on diagnostics is even less than 6% of the total health expenditure

    Diagnostics does not  receive the attention it deserves. It is the missing link for a sustainable healthcare system, providing immediate opportunities to reduce costs and to deliver higher quality of care.

    The Value of Diagnostics – The Study

    The Decision Group and Isala Klinieken proudly present the results of the study  “the Value of Diagnostics”. This study resulted in the first decision framework for diagnostics. It will help you and your organization to assess the value of different types of diagnostics and provides a much more efficient mechanism to take  reimbursement, investment and portfolio decisions.

    On Tuesday June 5th, the latest insights will be shared on our study results, the new framework and the method. The event will take place on 14.00u-18.00u in Hotel Wientjes, Stationsweg 7, Zwolle.

    To register for participation, please fill out the online application form or contact Kim Bruheim (k.bruheim@thedecisiongroup.nl). For more information on the Value of Diagnostics visit our special website and download the Executive Summary.

    See also

    – The Decision Group Healthcare Consulting
    Academic Connections
    –  Executive Education Programs Healthcare by affiliate The Decision Institute: 
    Clinical Management Workshop Series
    Masterclass Healthcare ‘New&Improved’

    Continue reading
  • Aantoonbaar Beter Symposium and Outcome Measures

    ‘ Measuring the quality of healthcare: principles and challenges’  was the title of the symposium Aantoonbaar Beter organized by the Nederlandse Federatie van Universitair Medische Centra (NFU) and Gezondheidsraad on April 5, 2012.  The interesting speakers and enthusiastic participants discussed the relevance and examples of outcome measures. Partcipating stakeholders all endorsed the relevance of outcome measures  – the guiding  the principle of  Value-Based Healthcare. This is truly a step in the right direction. But how to get Outcome Measurement started?

    The Decision Group & Value-Based Healthcare

    During the symposium many ideas were brought about on Outcome Measures. But ideas are not enough. It is important to convert these ideas into a practical approach for implementation.  The Decision Group helps to implement Value-Based Healthcare and our Outcome Measures methodology in your organization. We are Prof. Michael Porter’s European partner to roll out Value Based Healthcare in Europe and The Netherlands. Currently, The Decision Group is running various pilot projects. Our flagship project “Meetbaar Beter” sets and collects Outcome Measures for the heart centers of Catharina and Sint Antonius Hospitals. For more information about The Decision Group and Outcomes, you can visit our special website.

    See also

    – The Decision Group Healthcare Consulting
    Academic Connections

    Executive Education Programs Healthcare by affiliate The Decision Institute: 
    Clinical Management Workshop Series
    Masterclass Healthcare ‘New&Improved’

    Continue reading
  • Astra Zeneca and Antonius Conference on Cardio and Outcomes

    Outcome Measures in Cardiology

    Friday the 23rd of September St. Antonius hospital and AstraZeneca organized a successful conference on innovation and outcomes in cardiology. The speakers focused on the status and developments on healthcare quality measurement and reporting from the perspective of health insurers (Ms. D. Monissen, De Friesland), hospitals (Ir. D. M. Schraven, St. Antonius hospital), and cardiologists (prof. S.K. James, MD, PhD). Prof. dr. Fred van Eenennaam started off the conference with a presentation on the methodology and implementation of outcome measures in hospital care. Focus of his presentation are the newest insight and developments of The Decision Group from research and cooperation in their international network with The George Washington University, St. Gallen Universitat, and Harvard Business School. The conference showed a high-level of interaction between cardiologists, hospital executives, patient representatives and government policy makers.

    Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.

    ir. Maarten Koomans
    dr.
    Paul van der Nat
    prof. dr. Fred van Eenennaam

    Continue reading